Should I Buy XOMA? XOMA 2026 Analysis

Should You Buy Xoma Royalty Corp (XOMA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

24.550

1 Day change

-0.45%

52 Week Range

39.920

Analysis Updated At

2026/01/26

Given the user's beginner level, long-term investment preference, and the current data, XOMA is not a strong buy at this moment. The stock has significant negative catalysts, including ongoing legal investigations, a major Phase 3 trial failure, and declining financial performance metrics. While the company has potential long-term value due to its diversified royalty portfolio, the current risks outweigh the benefits for an impatient investor.

Technical Analysis

The technical indicators are mixed to bearish. The MACD is slightly positive but contracting, RSI is neutral at 44.402, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at $25.132, and resistance is at $27.573. The stock is trading pre-market at $26.7, close to its support level.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Lucid Capital's Buy rating with a $76 price target highlights the potential for long-term value creation through XOMA's diversified royalty portfolio, which mitigates single-asset risk.

Neutral/Negative Catalysts

Ongoing legal investigations into potential securities fraud, failure of a key Phase 3 trial (Rezolute's sunRIZE study), and a significant stock price drop of 22.76% following the news. These factors raise concerns about XOMA's financial health and reputation.

Financial Performance

In Q3 2025, revenue increased by 29.93% YoY to $9.35M, but net income dropped by -148.26% YoY to $8.98M, and EPS fell by -144.03% YoY to $0.7. Gross margin remained flat at 100%. The financial performance shows growth in revenue but significant declines in profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Lucid Capital initiated coverage with a Buy rating and a $76 price target, citing the company's diversified royalty portfolio and potential to collect over $1B in milestones and royalties over the next 15 years.

5 Analyst Rating

Wall Street analysts forecast XOMA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XOMA is 71 USD with a low forecast of 50 USD and a high forecast of 97 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 24.660

Low

Averages

High

Current: 24.660

Low

Averages

High

Lucid Capital

NULL -> Buy

initiated

$76

AI Analysis

2025-12-09

Reason

Lucid Capital

Price Target

$76

AI Analysis

2025-12-09

initiated

NULL -> Buy

Reason

Lucid Capital initiated coverage of Xoma with a Buy rating and $76 price target. The company has assembled a royalty portfolio from six commercial and nine Phase 3- stage small molecule and biological assets, the analyst tells investors in a research note. The firm says Xoma expects to collect over $1B in milestones and royalties over the next 15 years. Lucid believes that by building a diversified portfolio, the company mitigates single-asset risk while retaining exposure to substantial long-term value creation.

Benchmark

Robert Wasserman

Strong Buy

Initiates

$35

2025-04-17

Reason

Benchmark

Robert Wasserman

Price Target

$35

2025-04-17

Initiates

Strong Buy

Reason

Benchmark analyst Robert Wasserman initiated coverage of Xoma with a Buy rating and $35 price target. Xoma has expanded its royalty aggregate business through acquisitions and internal growth over the past several years, notes the analyst, who expects the R&D pipeline and recently completed commercial asset acquisitions to continue to drive double digit revenue growth over the next several years.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for XOMA

Unlock Now

XOMA Should I Buy

XOMA Should I Buy

Should You Buy Xoma Royalty Corp (XOMA) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch